Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00144313 · ClinicalTrials.gov registry record · Phase 4
VaxTeen Hepatitis B Vaccine Booster Study
A Phase 4 study, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
NCT00144313 is a Phase 4 study that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 60 participants.
The verdict
NCT00144313, a Phase 4 study, has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to determine immune status of adolescents who responded to a primary series of recombinant hepatitis B vaccine given at birth and to assess their response to a booster dose of vaccine.
Interventions
- BIOLOGICAL hepatitis B vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2005-08 |
| Est. Completion | 2006-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00144313
The ClinicalTrials.gov registry entry for NCT00144313 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Centers for Disease Control and Prevention, which has 139 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which hepatitis B vaccine is the first listed.
NCT00144313 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00144313 about?
NCT00144313 is a clinical study titled "VaxTeen Hepatitis B Vaccine Booster Study". The purpose of this study is to determine immune status of adolescents who responded to a primary series of recombinant hepatitis B vaccine given at birth and to assess their response to a booster dose of vaccine.
What is the current status of trial NCT00144313?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2005-08. Estimated completion is 2006-01.
What interventions are being tested in trial NCT00144313?
The interventions under investigation include: hepatitis B vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT00144313?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.